ID: ALA2288302

Max Phase: Preclinical

Molecular Formula: C19H20ClN3O2S

Molecular Weight: 389.91

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1ccc(NC2=NN(C(=O)COc3ccccc3Cl)C(C)(C)S2)cc1

Standard InChI:  InChI=1S/C19H20ClN3O2S/c1-13-8-10-14(11-9-13)21-18-22-23(19(2,3)26-18)17(24)12-25-16-7-5-4-6-15(16)20/h4-11H,12H2,1-3H3,(H,21,22)

Standard InChI Key:  DUHKJZJBILYDGU-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 389.91

Molecular Weight (Monoisotopic): 389.0965

AlogP: 4.72

#Rotatable Bonds: 4

Polar Surface Area: 53.93

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.61

CX Basic pKa:

CX LogP: 4.97

CX LogD: 4.97

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.82

Np Likeness Score: -1.41

References

1. KHAN MH, BANO Q, GIRI S, NIZAMUDDIN.  (1994)  Biological Activity of Some 2-Arylamino-4-aryloxyacetyl-2-1, 3, 4-thiadiazolidine Derivatives,  19  (4): [10.1584/jpestics.19.4_305]

Source

Source(1):

• Scientific Literature